Search results for: 'purotoxin 1'
- R1029 EZ Cap™ Cre mRNA (ΨUTP)Summary: Cre mRNA with Cap 1 structure, modified by ΨUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1030 EZ Cap™ Cre mRNA (m1Ψ)Summary: Cre mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1046 EZ Cap™ Cre mRNA (5-moUTP)Summary: Cre mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- BA3998 GNE-371Summary: GNE-371 is a highly efficient and selective chemical probe targeting the second bromo-terminal structural domain of human transcription initiation factor subunit 1 and transcription initiation factor-like subunit 1.
- P1130 Recombinant Human IL-19Summary: Human Interleukin-19 (IL-19) is encoded by the IL19 gene, which is located on the chromosome 1.
- BA2567 PDP-PfpSummary: PDP-Pfp is the active molecule used to target TM4SF1 extracellular loop 1 (ECL1).
- BA7038 SupercinnamaldehydeSummary: Supercinnamaldehyde is a potent activator of transient receptor potential anchor protein 1 (TRPA1).
- BA7067 EpaminuradSummary: Epaminurad (UR-1102) is an orally potent and selective (uric acid transporter 1) inhibitor.
- BA7081 HSD-016Summary: HSD-016 is a potent, selective, orally active type 1 11β-hydroxysteroid dehydrogenase inhibitor.
- BA7101 CMS-121Summary: CMS-121 is a quinolone derivative and an orally active inhibitor of acetyl coenzyme A carboxylase 1.